article Growth hormone’s influence on neuropsychiatric disorders 10 January 2024 | By Ellen Capon (Drug Target Review) The discovery of a mechanism involving anxiolytic effects of GH may lead to the development of new classes of anxiolytic drugs.
news New bacterial protein found to improve mitochondrial function 10 November 2023 | By Drug Target Review Protein released by C. burnetti interacts with antioxidising enzyme GPX4 to prevent cell damage and death.
news Melatonin could act as barrier against SARS-CoV-2 infection 28 January 2021 | By Victoria Rees (Drug Target Review) Researchers have suggested using melatonin in a nasal spray to create a protective barrier against SARS-CoV-2 in pre-symptomatic patients.
news Drug target to tackle COVID-19 inflammatory processes identified 2 December 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that the presence of the inflammasome mediated by NLRP3 is a marker and drug target for COVID-19-related cytokine storms.
news CNS tumour aggressiveness reduced with new molecule 8 November 2019 | By Rachael Harper (Drug Target Review) A microRNA inhibitor has been identified which reduced the sizes of aggressive CNS tumours and improved survival in mice.
news Biomarkers may help provide personalised treatment for brain cancer 13 April 2018 | By Drug Target Review Researchers in Brazil have identified seven biomarkers that could be used to indicate which glioma patients are likely to experience an aggressive form of the brain cancer.
